Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa

Acta Oto-Laryngologica, Supplement

Volumn , Issue 525, 1996, Pages 56-60

  Kondoh, Kiyotaka ^a   Hashiba, Motoyuki ^a   Baba, Shunkichi ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Bacterial biofilm; Hexose; Intractable infection; Macrolide; Polysaccharide synthesis; Scanning electron microscopy

Indexed keywords

CLARITHROMYCIN; ANTIINFECTIVE AGENT; POLITEF;

ARTICLE; BIOFILM; CONTROLLED STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; DRUG EFFECT; ELECTRON MICROSCOPY; HUMAN;

ANTI-BACTERIAL AGENTS; BIOFILMS; CLARITHROMYCIN; HUMANS; MICROSCOPY, ELECTRON; POLYTETRAFLUOROETHYLENE; PSEUDOMONAS AERUGINOSA;

EID: 0029658767     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nickel JC, Ruseska I, Costerton JW. Tobramycine resistance of cells of Pseudomonas aeruginosa growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother 1985; 27: 619-24.
2. Prosser BT, Taylor D, Cix BA, Cleeland R. Methods of evaluating effects of antibiotics on bacterial biofilm. Antimicrob Agents Chemother 1987; 31: 1502-6.
3. Warren JW, Mucie HL Jr, Berquist EJ, Hoppes JM. Sequelae and management of urinary infection in the patients requiring chronic catheterization. J Urol 1981; 125: 1-8.
4. Mayberry-Carson KJ, Tober-Meyer B, Smith JK, Lambe DW. Bacterial adherence and glycocalyx formation in osteomyelitis induced by Staphylococcus aureus. Infect Immun 1984; 43: 825-33.
5. Widmer AF, Wiestner A, Frei R, Zimmerli W. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 1991; 35: 741-6.
6. Marrie TJ, Costerton JW. Mode of growth of bacterial pathogens in chronic polymicrobial human osteomyelitis. J Clin Microbiol 1985; 22: 924-33.
7. Costerton JW, Cheng KJ. The bacterial glycocalyx in nature and disease. Ann Rev Microbial 1981; 35: 299-324.
8. Dickinson GM, Bisno AL. Infections associated with indwelling devices: concepts of pathogenesis. Antimicrob Agents Chemother 1989; 33: 598-601.
9. Yasuda H, Ajiki Y, Koga T, Kagawa H, Yokota T. Interaction between biofilm formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother 1993; 37: 1749-55.
10. Yasuda H, Ajiki Y, Koga T, Yokota T. Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. Antimicrob Agents Cheomother 1994; 38: 138-41.
11. Noritake O. Bacterial biofilm in chronic Airway infection. Jpn J Infect Dis 1993; 68: 138-51. (in Japanese).
12. WHO Technical Report Series, 1977; 610: 1-133.
13. Roe JH. The determination of sugar in blood and spinal fluid with anthron reagent. J Biol Chem 1955; 212: 335-9.
14. Gristina AG, Hobgood CD, Webb LX, Myrvik QN. Adhesive colonization of biomaterials and antibiotic resistance. Biomaterials 1987; 8: 423-6.
15. Hoyle BD, Costerton JW. Bacterial resistance to antibiotics: the role of biofilms. Prog Drug Res 1991; 37: 91-105.
16. Kudoh S, Uetake T, Hasegawa K, et al. Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchriolitis. Jpn J Thorac Dis 1987; 25: 632-43.
17. Hashiba M, Miyamoto N, Kimura T, Kobayashi T, Baba S. Efficacy of the erythromycin derivative, clarithromycin, in the treatment of chronic sinusitis. Am J Rhinol 1994; Suppl 8: 348-9.